Shearman & Sterling advised the Italian company Garofalo Health Care S.p.A. on its initial public offering of 20 million ordinary shares with no par value at a public offering price of €3.34 per share, resulting in gross proceeds to the company of approximately €66.8 million. The shares began trading on the Mercato Telematico Azionario of the Italian Stock Exchange under the ticker “GHC” on November 9, 2018.
Credit Suisse and Equita SIM acted as joint global coordinators and joint bookrunners for the offering.
Garofalo Health Care S.p.A. is a leading operator in the Italian accredited private healthcare sector for profitability and regional presence. The company offers a wide and diversified range of healthcare services supplied through a patient-centered approach, as well as the use of cutting-edge technologies and highly qualified staff, supplying services funded by the Regional Health System and to private patients.
The Shearman & Sterling team below was supported by associate Eunjee Chae (London-Tax) and trainee Guglielmo Sacco (Rome-Mergers & Acquisitions).